期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 55, 期 6, 页码 3002-3004出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.01420-10
关键词
-
资金
- Center for Anti-Infective Research and Development, Hartford Hospital
The limited treatment options available for carbapenemase-producing Klebsiella pneumoniae (KPC) have made it a formidable pathogen. Previously we have shown the enhanced activity of pharmacodynamically optimized doripenem against KPC. Capitalizing on KPC's increased affinity for ertapenem, we evaluated the efficacy of a combination of ertapenem and doripenem in both an in vitro chemostat and an in vivo murine thigh infection model. Overall, the combination of doripenem plus ertapenem demonstrated enhanced efficacy over either agent alone.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据